Blueprint Medicines Corp (BPMC) — Capital Reinvestment Ratio
Latest as of September 2020:
0.00x
Blueprint Medicines Corp (BPMC) has a Capital Reinvestment Ratio of 0.00x as of September 2020, meaning it reinvests 0% of its operating cash flow ($622.33 Million) in capital expenditures ($6.00K). See BPMC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$622.33 Million
USD
Capital Expenditures
$6.00K
USD
Data as of
Sep 2020
Most recent filing
Blueprint Medicines Corp Capital Reinvestment Ratio (2020–2020)
This chart tracks Blueprint Medicines Corp's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Blueprint Medicines Corp (2020–2020)
Year-by-year Capital Reinvestment Ratio for Blueprint Medicines Corp from 2020 to 2020. For live market cap and broader valuation context, see Blueprint Medicines Corp market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.01x | $387.04 Million | $3.16 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow